Ayala Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This ESG rating includes 17 United Nations Sustainable Development Goals including: 'No Poverty', 'Sustainable Cities & Communities' and 'Life on Land'. If you are employed by Ayala Pharmaceuticals Inc and you wish to use your Sustainability rating, please get in touch. Complete ESG assessment of Ayala Pharmaceuticals Inc can be reached by signing in.
Ayala Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.7, social score of 1.6 and governance score of 4.0.
2.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1353 | Vera Therapeutics Inc | 2.9 | Medium |
| 1353 | Veracyte Inc | 2.9 | Medium |
| 1393 | Ayala Pharmaceuticals Inc | 2.8 | Medium |
| 1393 | Bioventix PLC | 2.8 | Medium |
| 1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Ayala Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Ayala Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Ayala Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Ayala Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Ayala Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Ayala Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Ayala Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Ayala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, which is an intravenous injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, an oral injectable small molecule GSI that is in Phase I clinical trial for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.